Clinical Trials
15 trialsNCT05251805 2025-06-08
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
Phase NA Terminated
NCT01186367 2025-02-10
Excite
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT04273893 2024-12-10
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
Phase NA Active not recruiting
NCT04040244 2023-10-11
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Wake Forest University Health Sciences
Phase NA Terminated
NCT02696759 2022-03-16
Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
University of Arkansas
Phase NA Terminated
NCT03956615 2021-12-01
MUM
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT03998189 2021-11-05
Metabolic and Microbial Profiling of Lung Cancer
Wake Forest University Health Sciences
Phase NA Terminated
NCT02485964 2021-10-07
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
University of Arkansas
Phase NA Completed
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT00685750 2019-06-20
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
Phase NA Terminated
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02241187 2017-09-27
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01048099 2016-01-29
Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase NA Completed
NCT01209520 2015-02-24
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Phase NA Completed